Nouveau Life Pharmaceuticals, Inc.
NOUV · OTC
12/31/2024 | 6/30/2007 | 6/30/2006 | 6/30/2005 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $4 | $4 | $1 |
| Short-Term Investments | – | $0 | $0 | $0 |
| Receivables | – | $0 | $0 | $0 |
| Inventory | – | $0 | $0 | $0 |
| Other Curr. Assets | – | $0 | $0 | $0 |
| Total Curr. Assets | – | $4 | $29 | $1 |
| Property Plant & Equip (Net) | – | $821 | $0 | $0 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $506 | $0 | $0 |
| Long-Term Investments | – | $0 | $0 | $0 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | $0 | $0 | $0 |
| Total NC Assets | – | $1,326 | $0 | $0 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $1,330 | $29 | $1 |
| Liabilities | – | – | – | – |
| Payables | – | $137 | $137 | $63 |
| Short-Term Debt | – | $57 | $47 | $297 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $30 | $29 | $47 |
| Other Curr. Liab. | – | $556 | $536 | $327 |
| Total Curr. Liab. | – | $781 | $675 | $738 |
| LT Debt | – | $10 | $0 | $0 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $223 | $0 | $0 |
| Total NC Liab. | – | $233 | $223 | $223 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $0 | $0 | $0 |
| Total Liabilities | – | $1,014 | $898 | $961 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $30 | $26 | $25 |
| Retained Earnings | – | -$2,807 | -$2,449 | -$2,193 |
| AOCI | – | $676 | $547 | $360 |
| Other Equity | – | $2,417 | $2,192 | $939 |
| Total Equity | – | $316 | -$869 | -$960 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $1,330 | $29 | $1 |
| Net Debt | $0 | $64 | $44 | $296 |